Radiation Dermatitis Treatment Market
Radiation Dermatitis Treatment Market Analysis Report By Product (Oral Medication-based Radiation Dermatitis Treatment, Topical Radiation Dermatitis Treatment, Dressing-based Radiation Dermatitis Treatment), By Distribution Channel - Regional Forecast 2021 to 2031
Analysis of Radiation Dermatitis Treatment market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Radiation Dermatitis Treatment Market Outlook
The global radiation dermatitis treatment market to register a high market value, reaching US$ 700 Mn by the end of the 2021 to 2031 assessment period, registering a CAGR of 5%. In the short-run, by 2021-end, sales of radiation dermatitis products are likely to close in at US$ 429.7 Mn. High demand is anticipated for topical hydrophilic creams, likely to yield 33% of global market revenue.
| Report Attributes | Details |
|---|---|
| Market Value (2021) | US$ 429.7 Mn |
| Projected Market Valuation (2031) | US$ 700 Mn |
| Growth Rate (2021 to 2031) | 5% CAGR |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Demand Analysis of Radiation Dermatitis Treatment 2016 to 2020 Vs Future Outlook 2021 to 2031
Recent estimates from Fact.MR- a market research & competitive intelligence provider- establishes that demand for radiation dermatitis treatment accelerated at a steady pace from 2016 to 2020, registering a CAGR worth 4% amid rising frequencies of advanced radiation-based treatment for different grades of cancers.
During the worst of COVID-19, prospects for radiation dermatitis treatment declined considerably, especially across hospitals and clinics, attributed to increased apprehensions about transmitting the novel coronavirus to patients. At the same time, home based treatment in the form of topical creams available at online and retail stores increased.
Future growth prospects are reliant on the incorporation of biocompatible and nanoparticle compounds, which include self-healing and antimicrobial properties. Based on all aforementioned trends, it is evident that the global market for radiation dermatitis treatment is expected to register positive growth, clocking a CAGR of 5% from 2021 to 2031.
How is Rising Prevalence of Cancer Driving Demand for Radiation Dermatitis Treatment?
According to the International Agency for Cancer Research (IARC), the number of new cancer cases rose to 19.3 million, with 10 million deaths during the year. By 2040, this number shall surpass 29 million, while deaths will increase to more than 16 million. Consequently, patients are seeking radiation treatment as it is highly effective in eradicating some of the worst cancers.
While radiation therapy accounts for 40% of all cancer cures globally, studies have indicated that patients receiving them are at heightened risk of suffering from radiation burns which induce numerous skin problems. Hence, uptake of radiation dermatitis dressings and treatment products is inclining across key regions.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Prospects are in Store for Biocompatible & Biodegradable Nanomaterials?
Manufacturers are bolstering production capacities in wound dressings which are highly elastic and flexible. However, it has been found that these dressings in some cases may damage fragile skin and may not prevent maceration.
This has created a need for new biocompatible and biodegradable nanomaterials that help in regulating all phases of wound healing. Companies in the radiation dermatitis treatment market are increasing their R&D capabilities to develop dressings that incorporate antibacterial and self-healing properties.
How are Alternative Radiation Therapies Catalyzing Growth Prospects?
Modern radiotherapy techniques, which include intensity-modulated radiation therapy (IMRT) and proton therapy, can diminish the risk for radiation dermatitis by more accurately targeting tumor, thereby saving the normal tissue from repeated assault.
Higher adoption of these techniques, especially in developed regions, as they result in fewer severe rated cases of radiation dermatitis. This is likely to restrain uptake of chronic radiation dermatitis treatment products to a significant extent.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Analysis
Surging Skin Cancer Treatment Impelling Radiation Dermatitis Treatment in the U.S?
According to the Skin Cancer Foundation, over 9,500 people in the U.S are diagnosed with skin care daily, with over 2/3rd of the people succumbing every hour. More than 5.4 million cases of non-melanoma skin cancer were treated in over 3.3 million people in 2012. Also, at least one in five Americans will develop skin cancer by the age of 70.
Hence, the scope for radiation dermatitis has increased in recent years. As per the American Society for Radiation Oncology (ASTRO), nearly 95% of patients receiving radiation therapy suffer from some degree of radiation dermatitis, thus requiring treatment for the same, which is broadening avenues for the market.
Numerous topical steroid creams and oral medication manufacturers have flourished in the U.S market for radiation dermatitis treatment in recent years. For instance, AdvaCare Pharma offers the CortiCareTM Hydrocortisone Ointment, which helps reduce inflammation, redness and swelling. Similarly, the 3MTM CavilonTM No Sting Barrier Film offers a sting-free formula which forms a transparent barrier over the skin, protecting it from friction and aids in moisture management. Based on these developments, the market in the U.S will likely surge at a CAGR of 5.3% until 2031.
How is Treatment for Breast Cancer Augmenting Prospects across India?
According to Fact.MR, radiation dermatitis treatment products sales in India are expected to register a CAGR worth 6% across the 2021 to 2031 forecast period. While numerous skin cancer treatment approaches are widening its scope, treatment for breast cancer in particular is expected to provide major tailwinds to market growth.
According to statistics published by Cytecare Cancer Hospitals, breast cancer accounts for 14% of cancers in Indian women. Every four minutes, an Indian woman is diagnosed with breast cancer. The incidence is especially high across the metro cities, account for over 1/4th of all female cancers. Hence, patients are seeking advanced radiation based treatment.
Overall incidence of grade 1-2 acute erythematous reactions resulting from radiation based treatment is 80-90%, while moist desquamation is observed in around 10-15% of the patients. Some studies have reported increased grade 1-2 late fibrosis in patients undergoing breast conservation surgery and hypo fractionated radiotherapy.
Will China Be a Lucrative Market for Radiation Dermatitis Treatment?
China is likely to offer highly attractive growth prospects, attributing to the ever-widening popularity of Traditional Chinese Medicine (TCM). TCM holds promising potentials in minimizing the impact of radio-dermatitis in patients with neck and head cancer. A CAGR of 5.8% is projected for the Chinese market.
Companies in the acute radiation dermatitis treatment market are capitalizing on this opportunity to innovate in pastes that improve the symptoms of skin reaction caused due to radiotherapy. Honeysuckle is emerging as one of the key ingredients in TCM for the treatment of carbuncles, while medicines containing angelica sinensis appear to nourish and activate the blood and relieve pain by promoting coronary circulation.
Category-wise Insights
Why are Topical Hydrophilic Creams Attracting Attention?
By product, demand for topical hydrophilic creams is anticipated to surge impressively, attributed to its ease of application, cost-effectiveness and enhanced bioavailability. These creams impart moisture to prevent dry, rough, itchy and scaly skin. A market share of 33% is anticipated for hydrophilic creams in the long run.
Radiation treatment often eliminates moisture content from the skin, rendering it extremely dry and irritated, thus requiring high amounts of water to reduce this constant irritation. 3M Company, for instance, offers the CavilonTM Advanced Skin Protectant, comprising of a hydrophilic composition of elastomeric polymer and a non-stinging solvent.
Will Retail & Online Pharmacies Register High Radiation Dermatitis Treatment Product Sales?
By distribution channel, Fact.MR expects radiation dermatitis treatment product sales to expand swiftly across retail pharmacies, attributed to increased incidence of home-based and self-treating prescriptions across major regions. Furthermore, retail pharmacies are easily accessible to patients.
Simultaneously, online pharmacies are gaining more prominence, given that an increasing number of patients seek virtual alternatives amid increased penetration of digital literacy which has enhanced access to smart gadgets and the internet. Moreover, these channels offer high discounts and home delivery options, making them the go-to option for customers. Collectively, both channels will likely account for 45% of total revenue.
Competitive Landscape
Prominent manufacturers of radiation dermatitis treatment products are concentrating on expanding their presence in wound care, attributed to the increased frequency of surgery induced wounds experienced while undergoing radiation treatment. Notable developments are as follows:
- In January 2021, Integra Lifesciences Holdings Inc. acquired ACell Inc. and its proprietary MatriStem UBMTM technology to further enhance its complex wound management solutions
- In 2019, Molnlycke Health Care AB collaborated with Zuellig Pharma to strengthen its advanced wound care solutions across South East Asia. This follows the successful acquisition of SastoMed in July 2018, augmenting Mölnlycke’s range of wound care solutions with SastoMed’s ground-breaking, oxygen-therapy based solutions for chronic wounds
Radiation Dermatitis Treatment Market- Report Scope
| Attribute | Details |
|---|---|
| Forecast Period | 2016 to 2020 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | US$ Mn for Value & ‘000 Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Covered |
U.S, Canada, Brazil, Mexico, Germany, U.K, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, Australia, New Zealand, GCC, Turkey, South Africa |
| Key Segments Covered | Product, Distribution Channel, Region |
| Key Companies Profiled | 3M Company; MÖLnlycke Health Care AB; Smith & Nephew Plc; Integra Lifesciences Holdings Corporation; Intermed S.A; ConvaTech Group; BMG Pharma S.p.A |
| Pricing | Available upon Request |
Key Segments Covered
-
Product
- Oral Medication-based Radiation Dermatitis Treatment
- Corticosteroids
- Oral Analgesics & Antibiotics
- Topical Radiation Dermatitis Treatment
- Hydrophilic Creams
- Topical Antibiotics
- Dressing-based Radiation Dermatitis Treatment
- Hydrogel
- Hydrocolloid
- No Sting Barrier Film
- Honey Impregnated Gauze
- Silicone Coated Dressing
- Others
- Oral Medication-based Radiation Dermatitis Treatment
-
Distribution Channel
- Radiation Dermatitis Treatment through Hospital Pharmacies
- Radiation Dermatitis Treatment through Retail Pharmacies
- Radiation Dermatitis Treatment through Online Pharmacies
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 9. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product
- 9.1. Oral Medication
- 9.2. Topical
- 9.3. Dressings
- 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Distribution Channel
- 10.1. Hospital Pharmacies
- 10.2. Retail Pharmacies
- 10.3. Online Pharmacies
- 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 13. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 17. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 18. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 19. Key and Emerging Countries Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. 3M Company
- 21.2. Molnlycke Health Care AB
- 21.3. Smith & Nephew Plc
- 21.4. Integra Lifesciences Holdings Corporation
- 21.5. Intermed S.A.
- 21.6. ConvaTech Group Plc
- 21.7. BMG PHARMA S.p.A.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment2016 to 2031, By Product
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 08: Latin America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment2016 to 2031, By Product
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 11: Europe Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031,By Product
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 14: South Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 17: East Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 20: Oceania Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment2016 to 2031, By Product
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast2021 to 2031, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2016 to 2020
Figure 02: Global Market Volume Forecast (in 000' Units), 2021 to 2031
Figure 03: Radiation Dermatitis TreatmentPricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Radiation Dermatitis TreatmentPricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Market Value Analysis (US$ Mn), 2016 to 2020
Figure 06: Global Market Value Forecast (US$ Mn), 2021 to 2031
Figure 07: Global Market Absolute $ Opportunity, 2021 to 2031
Figure 08: Global Market Share Analysis (%),By Product, 2021 to 2031
Figure 09: Global Market Y-o-Y Analysis (%), By Product, 2021 to 2031
Figure 10: Global Market Attractiveness Analysis by Product, 2021 to 2031
Figure 11: Global Market Share Analysis (%), By Distribution Channel, 2021 to 2031
Figure 12: Global Market Y-o-Y Analysis (%), ByDistribution Channel, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis byDistribution Channel, 2021 to 2031
Figure 14: Global Market Share Analysis (%), By Region, 2021 to 2031
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2031
Figure 17: North America Market Value Share, By Product, 2021 (E)
Figure 18: North America Market Value Share, ByDistribution Channel, 2021 (E)
Figure 19: North America Market Value Share, By Country, 2021 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 21: North America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 22: North America Market Attractiveness Analysis by Product, 2021 to 2031
Figure 23: North America Market Attractiveness Analysis byDistribution Channel, 2021 to 2031
Figure 24: North America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 25: Latin America Market Value Share, By Product, 2021 (E)
Figure 26: Latin America Market Value Share, ByDistribution Channel, 2021 (E)
Figure 27: Latin America Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 29: Latin America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 30: Latin America Market Attractiveness Analysis by Product, 2021 to 2031
Figure 31: Latin America Market Attractiveness Analysis byDistribution Channel, 2021 to 2031
Figure 32: Latin America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 33: Europe Market Value Share, By Product, 2021 (E)
Figure 34: Europe Market Value Share, ByDistribution Channel, 2021 (E)
Figure 35: Europe Market Value Share, By Country, 2021 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2016 to 2020
Figure 37: Europe Market Value Forecast (US$ Mn), 2021 to 2031
Figure 38: Europe Market Attractiveness Analysis by Product,2021 to 2031
Figure 39: Europe Market Attractiveness Analysis byDistribution Channel, 2021 to 2031
Figure 40: Europe Market Attractiveness Analysis by Country, 2021 to 2031
Figure 41: South Asia Market Value Share, By Product, 2021 (E)
Figure 42: South Asia Market Value Share, ByDistribution Channel, 2021 (E)
Figure 43: South Asia Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 45: South Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 46: South Asia Market Attractiveness Analysis by Product,2021 to 2031
Figure 47: South Asia Market Attractiveness Analysis byDistribution Channel, 2021 to 2031
Figure 48: South Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 49: East Asia Market Value Share, By Product, 2021 (E)
Figure 50: East Asia Market Value Share, By Distribution Channel, 2021 (E)
Figure 51: East Asia Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 53: East Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 54: East Asia Market Attractiveness Analysis by Product,2021 to 2031
Figure 55: East Asia Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 56: East Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 57: Oceania Market Value Share, By Product, 2021 (E)
Figure 58: Oceania Market Value Share, By Distribution Channel, 2021 (E)
Figure 59: Oceania Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2016 to 2020
Figure 61: Oceania Market Value Forecast (US$ Mn), 2021 to 2031
Figure 62: Oceania Market Attractiveness Analysis by Product, 2021 to 2031
Figure 63: Oceania Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 64: Oceania Market Attractiveness Analysis by Country, 2021 to 2031
Figure 65: Middle East and Africa Market Value Share, By Product, 2021 (E)
Figure 66: Middle East and Africa Market Value Share, ByDistribution Channel, 2021 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2016 to 2020
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2021 to 2031
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product,2021 to 2031
Figure 71: Middle East and Africa Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2021 to 2031
Figure 73: U. S. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Market Value Share, By Product, 2021 (E)
Figure 75: U. S. Market Value Share, By Distribution Channel, 2021 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Market Value Share, By Product, 2021 (E)
Figure 78: Canada Market Value Share, ByDistribution Channel, 2021 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Market Value Share, By Product, 2021 (E)
Figure 81: Mexico Market Value Share, ByDistribution Channel, 2021 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Market Value Share, By Product, 2021 (E)
Figure 84: Brazil Market Value Share, ByDistribution Channel, 2021 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Market Value Share, By Product, 2021 (E)
Figure 87: U. K. Market Value Share, ByDistribution Channel, 2021 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Market Value Share, By Product, 2021 (E)
Figure 90: Germany Market Value Share, ByDistribution Channel, 2021 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Market Value Share, By Product, 2021 (E)
Figure 93: France Market Value Share, ByDistribution Channel, 2021 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Market Value Share, By Product, 2021 (E)
Figure 96: Italy Market Value Share, ByDistribution Channel, 2021 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Market Value Share, By Product, 2021 (E)
Figure 99: Spain Market Value Share, ByDistribution Channel, 2021 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Market Value Share, By Product, 2021 (E)
Figure 102: Russia Market Value Share, ByDistribution Channel, 2021 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Market Value Share, By Product, 2021 (E)
Figure 105: China Market Value Share, By Distribution Channel, 2021 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Market Value Share, By Product, 2021 (E)
Figure 108: Japan Market Value Share, ByDistribution Channel, 2021 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Market Value Share, By Product, 2021 (E)
Figure 111: South Korea Market Value Share, ByDistribution Channel, 2021 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Market Value Share, By Product, 2021 (E)
Figure 114: India Market Value Share, ByDistribution Channel, 2021 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Market Value Share, By Product, 2021 (E)
Figure 117: ASEAN Market Value Share, ByDistribution Channel, 2021 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Market Value Share, By Product, 2021 (E)
Figure 120: Australia Market Value Share, ByDistribution Channel, 2021 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Market Value Share, By Product, 2021 (E)
Figure 123: New Zealand Market Value Share, ByDistribution Channel, 2021 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Market Value Share, By Product, 2021 (E)
Figure 126: GCC Countries Market Value Share, ByDistribution Channel, 2021 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Market Value Share, By Product, 2021 (E)
Figure 129: Turkey Market Value Share, ByDistribution Channel, 2021 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Market Value Share, By Product, 2021 (E)
Figure 132: South Africa Market Value Share, ByDistribution Channel, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the radiation dermatitis treatment industry worth?
As of 2021, Fact.MR expects radiation dermatitis demand to reach US$ 429.7 Mn
What is the expected growth trajectory of the market for radiation dermatitis until 2031?
From 2021 to 2031, radiation dermatitis treatment products sales will likely surge at a CAGR of 5%
At what value will the radiation dermatitis treatment industry be valued in 2031?
As per Fact.MR’s analysis, the market for radiation dermatitis treatment is likely to be valued at US$ 700 Mn in 2031
What was the CAGR for the market in the past 5 years?
From 2016 to 2020, radiation dermatitis treatment demand surged at around 4% CAGR
How opportunistic is the market for radiation dermatitis treatment in the U.S?
According to Fact.MR, radiation dermatitis treatment product sales are likely to surge at a CAGR of 5.3% until 2031
Will India emerge as a promising investment hub for radiation dermatitis treatment providers?
India is expected to emerge as the fastest growing landscape for radiation dermatitis treatment, registering a CAGR of 6%
What are the growth prospects across China?
China is anticipated to register a CAGR of 5.8% for radiation dermatitis treatment in the decade spanning from 2021 to 2031
Which radiation dermatitis treatment product is highly preferred?
Topical hydrophilic creams are the most sought after, registering a market share of 33%
Which distribution channels will likely register maximum sales of radiation dermatitis products?
Retail and online pharmacies will jointly account for 45% of total radiation dermatitis products sales
Radiation Dermatitis Treatment Market